Evidence map›Paper›PMID 32588807›Full record

ArticleThe American journal of tropical medicine and hygiene2020

Elimination of

Moses N Katabarwa, Peace Habomugisha, Annet Khainza, David Oguttu, Edson Byamukama, James Katamanywa, Thomson Isingooma, Fredrick Bwenume, Christine Nahabwe, Monica Ngabirano and 4 more

Open access · hybridAbstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.1field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 133 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Can mass drug administration of moxidectin accelerate onchocerciasis elimination in Africa?Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Moses N Katabarwa1The Carter Center, Atlanta, Georgia.
Peace Habomugisha2The Carter Center, Kampala, Uganda.
Annet Khainza2The Carter Center, Kampala, Uganda.
David Oguttu3Vector Control Division, Ministry of Health, Kampala, Uganda.
Edson Byamukama2The Carter Center, Kampala, Uganda.
James Katamanywa4Vector Control, Kabarole, Uganda.
Thomson Isingooma5Hoima District Health Service, Hoima, Uganda.
Fredrick Bwenume5Hoima District Health Service, Hoima, Uganda.
Christine Nahabwe3Vector Control Division, Ministry of Health, Kampala, Uganda.
Monica Ngabirano3Vector Control Division, Ministry of Health, Kampala, Uganda.
Paul Akampurira3Vector Control Division, Ministry of Health, Kampala, Uganda.
Lauri Bernard1The Carter Center, Atlanta, Georgia.
Thomas R Unnasch6Center for Global Health Infectious Disease Research, University of South Florida, Tampa, Florida.
Frank Richards1The Carter Center, Atlanta, Georgia.
Ministry of Health · UGCarter Center · USHoima Hospital · UGUniversity of South Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Wambabya-Rwamarongo onchocerciasis focus is one of the eight foci Uganda verified using the WHO verification guidelines. The approach for elimination was twice yearly treatment with ivermectin for every round, treating at least 90% of all the eligible population. This was in combination with vector elimination using Abate

Indexed as

AnimalsAntiparasitic AgentsBrachyuraDisease EradicationHumansIvermectinOnchocerciasisSimuliidaeTemefosUgandaAntiparasitic AgentsIvermectinTemefos

Identifiers

PMID32588807
PMCPMC7470550
OpenAlexW3037432831

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.